Close Menu

Seems many are speaking up about the attempt of New York and California to restrict personal genetic testing. Over at The Personal Genome, Jason Bobe calls the cease-and-desist letters a form of "biocensorship," while an editorial in Nature Biotechnology wonders how personalized medicine is to advance if the current state of medicine isn't changed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A South African university has told the Wellcome Sanger Institute to return DNA samples it has from indigenous African communities, The Times reports.

The University of California, Berkeley's Rasmus Nielsen and Xinzhu Wei have retracted their CCR5 gene paper due to a technical artifact.

 

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.